title: [Current aspects of ototoxicity : Local ototoxic effects, diagnosis, prevention, and treatment].
abstract: The otorhinolaryngologist is often involved in an interdisciplinary approach to diagnose ototoxic side effects. Under certain conditions, chemical agents-particularly drugs-can have ototoxic effects. This is not only true for systemic administration, but also for local application (e.g., transdermal and transtympanal). Identifying and avoiding ototoxicity is still a challenge in clinical practice. The audiological monitoring of patients receiving potentially cochleotoxic drugs is now standardized. For diagnosis of suspected vestibulotoxic effects, the video head impulse test and vestibular evoked myogenic potentials seem to be suitable procedures for objective assessment. The early detection of such ototoxic effects has important implications for the prevention of hearing and balance disorders. Recent studies show that intratympanic delivery of medications might play an important role in the limitation of ototoxically induced hearing loss. In peripheral vestibulopathies with episodic vertigo, which strongly affect quality of life, ototoxic effects can be used for therapeutic purposes.
authors: HNO-Gemeinschaftspraxis, Main-Taunus-Zentrum, 65843, Sulzbach (Taunus), Deutschland, Leif.Walther@hno-praxis-sulzbach.de.
authors: L E
authors: LE
authors: Walther
authors: R
authors: R
authors: Hülse
authors: K
authors: K
authors: Lauer
authors: A
authors: A
authors: Wenzel
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control*; D004427:Ear Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control*; D006801:Humans; D004364:Pharmaceutical Preparations; D015837:Vestibular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control*
chemical_list: D004364:Pharmaceutical Preparations
references: Neurology. 2009 Oct 6;73(14):1134-41
references: 19805730
references: Otolaryngol Head Neck Surg. 2014 Jun;150(6):983-90
references: 24618499
references: Laryngoscope. 2002 Apr;112(4):689-95
references: 12150525
references: Expert Opin Drug Saf. 2006 May;5(3):383-99
references: 16610968
references: Otolaryngol Head Neck Surg. 2014 Feb;150(2):161-8
references: 24492208
references: Laryngorhinootologie. 1991 Sep;70(9):457-62
references: 1930486
references: Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1293-7
references: 22907028
references: Front Neurol. 2014 Apr 29;5:66
references: 24808890
references: HNO. 2000 Jan;48(1):18-21
references: 10663044
references: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005608
references: 16437533
references: J Neurol Neurosurg Psychiatry. 2008 Mar;79(3):284-8
references: 17635972
references: Trends Pharmacol Sci. 2013 Aug;34(8):458-69
references: 23769626
references: Laryngorhinootologie. 2002 Dec;81(12):853-6
references: 12486621
references: Acta Otolaryngol. 2001 Jul;121(5):569-72
references: 11583387
references: Acta Otolaryngol Suppl. 1995;519:60-5
references: 7610893
references: Cochlear Implants Int. 2014 May;15 Suppl 1:S62-4
references: 24869447
references: J Laryngol Otol. 2001 Nov;115(11):879-80
references: 11779301
references: Laryngoscope. 2008 Oct;118(10):1793-800
references: 18806480
references: Indian J Otolaryngol Head Neck Surg. 2011 Jul;63(3):255-9
references: 22754805
references: ORL J Otorhinolaryngol Relat Spec. 2003 Mar-Apr;65(2):84-90
references: 12824729
references: Case Rep Otolaryngol. 2013;2013:168391
references: 23533884
references: Otol Neurotol. 2008 Oct;29(7):910-3
references: 18698269
references: Z Laryngol Rhinol Otol. 1968 Jun;47(6):442-8
references: 5302956
references: Otol Neurotol. 2002 Nov;23(6):967-74
references: 12438864
references: Laryngorhinootologie. 1994 Jun;73(6):331-7
references: 8060454
references: Laryngorhinootologie. 1997 Jun;76(6):368-70
references: 9333282
references: HNO. 2013 Sep;61(9):730-7
references: 23913192